| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WISH | Class A Common Stock | Conversion of derivative security | $0 | +20,668 | +21% | $0.000000 | 118,867 | 15 Nov 2021 | Direct | F1 |
| transaction | WISH | Class A Common Stock | Options Exercise | $0 | +14,741 | +12% | $0.000000 | 133,608 | 15 Nov 2021 | Direct | |
| transaction | WISH | Class A Common Stock | Options Exercise | $0 | +145,264 | +109% | $0.000000 | 278,872 | 15 Nov 2021 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -9,560 | -6.2% | $0.000000 | 143,420 | 15 Nov 2021 | Class B Common Stock | 9,560 | $0.000000 | Direct | F2, F3 |
| transaction | WISH | Class B Common Stock | Options Exercise | $0 | +9,560 | $0.000000 | 9,560 | 15 Nov 2021 | Class A Common Stock | 9,560 | Direct | F4, F5 | ||
| transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -5,900 | -4.5% | $0.000000 | 123,940 | 15 Nov 2021 | Class B Common Stock | 5,900 | $0.000000 | Direct | F3, F6 |
| transaction | WISH | Class B Common Stock | Options Exercise | $0 | +5,900 | +62% | $0.000000 | 15,460 | 15 Nov 2021 | Class A Common Stock | 5,900 | Direct | F4, F5 | |
| transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -5,208 | -2.8% | $0.000000 | 180,088 | 15 Nov 2021 | Class B Common Stock | 5,208 | $0.000000 | Direct | F3, F7 |
| transaction | WISH | Class B Common Stock | Options Exercise | $0 | +5,208 | +34% | $0.000000 | 20,668 | 15 Nov 2021 | Class A Common Stock | 5,208 | Direct | F4, F5 | |
| transaction | WISH | Class B Common Stock | Conversion of derivative security | $0 | -20,668 | -100% | $0.000000* | 0 | 15 Nov 2021 | Class A Common Stock | 20,668 | Direct | F1, F4, F5 | |
| transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -14,741 | -6.7% | $0.000000 | 206,368 | 15 Nov 2021 | Class A Common Stock | 14,471 | $0.000000 | Direct | F8, F9 |
| transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -145,264 | -25% | $0.000000 | 435,793 | 15 Nov 2021 | Class A Common Stock | 145,264 | $0.000000 | Direct | F7, F9, F10 |
| Id | Content |
|---|---|
| F1 | Represents the conversion of Class B Common Stock, issued upon settlement of vested Restricted Stock Units ("RSUs"), into Class A Common Stock held of record by the Reporting Person. |
| F2 | Each RSU represents a contingent right to receive one share of Issuer's Class B Common Stock. Subject to the reporting person's continued service, 20% of the RSUs vested on February 5, 2019, and 1/60th of the RSUs vest monthly thereafter for a period of 4 years. |
| F3 | This reported transaction represents the settlement of RSUs vested as of November 15, 2021. |
| F4 | All shares of Class B Common Stock will automatically convert, on a one-for-one basis, into shares of Class A Common Stock on the earliest of (i) any transfer of the Class B Common Stock by the holder, whether or not for value, subject to certain exceptions, (ii) the 7-year anniversary of the closing date of the issuer's initial public offering, (iii) the date on which the number of outstanding shares of Class B Common Stock represents less than 5% of the aggregate combined number of outstanding shares of Class A Common Stock and Class B Common Stock, (iv) the date specified by a vote of the holders of a majority of the then outstanding shares of Class B common stock, or (v) a date that is between 90 and 270 days, as determined by the board of directors, after the death or permanent incapacity of the issuer's founder, CEO, and Chairperson. |
| F5 | Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon any transfer, whether or not for value, except certain permitted transfers. |
| F6 | Each RSU represents a contingent right to receive one share of Issuer's Class B Common Stock. Subject to the reporting person's continued service, the RSUs vest on a monthly basis over a period of 4 years beginning on May 1, 2019, with 10% of the total RSUs vesting over the first year, 20% of the total vesting over the second year, 30% of the total vesting over the third year, and 40% of the total vesting over the fourth year. |
| F7 | Each RSU represents a contingent right to receive one share of Issuer's Class B Common Stock. Subject to the reporting person's continued employment, 1/48th of the RSUs vest on a monthly basis beginning on October 1, 2020 for a period of 4 years. |
| F8 | Subject to the reporting person's continuous service, 6.25% of the RSUs will vest on a quarterly basis beginning on November 15, 2021 (with all quarterly vesting events occurring on a "Company Vesting Date" of February 15, May 15, August 15, or November 15). Vested RSUs will settle on or following the vesting date, but in any event within 60 days following the vesting date (unless the Reporting Person and the Company have agreed in writing to a later settlement date pursuant to procedures the Company may prescribe at its discretion). |
| F9 | The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive on share of Issuer's Class A Common Stock for each RSU. |
| F10 | Subject to the reporting person's continuous service, 25% of the RSUs will vest on a quarterly basis beginning on November 15, 2021 (with all quarterly vesting events occurring on a "Company Vesting Date" of February 15, May 15, August 15, or November 15). Vested RSUs will settle on or following the vesting date, but in any event within 60 days following the vesting date (unless the Reporting Person and the Company have agreed in writing to a later settlement date pursuant to procedures the Company may prescribe at its discretion). |